The global cannabis extract market size is expected to reach USD 23.7 billion by 2025, according to a new report by Grand View Research, Inc., expanding at a 22.1% CAGR over the forecast period.
Growing preference for cannabis extracts such as oils and tinctures, rising legalization of marijuana in various countries, and increase in the adoption of medical marijuana for treatment of various chronic diseases such as Alzheimer’s, cancer, arthritis, and anxiety are key factors promoting cannabis concentrates market growth.The marijuana industry is booming due to increasing awareness about its medical benefits.
Decriminalization and/or legalization of medical marijuana in some countries has led to a significant decrease in the black market as people are resorting to legally purchasing marijuana for medical use.Cannabis oils and tinctures can be used for manufacturing edibles and topicals other than smoking.
These are generally used for treatment of conditions such as cancer, mental disorders, and nausea as well as for recreational purposes such as vaping.
In terms of legality, laws pertaining to medical marijuana extracts are much more lenient compared to that of dried buds, which involve smoking.
Further key findings from the report suggest:In 2018, oils held the largest revenue share of 65.7% owing to their ease of availability and low priceThe full spectrum segment was valued at USD 3.3 billion in 2018, owing to its entourage effect - a synergistic relationship between cannabinoids and terpenes that exhibits an increase in the healing properties of each cannabinoidMarijuana isolates are anticipated to emerge as the second largest type segment owing to its several advantages that have increased its adoption.
Global Cannabinoid Drugs Market: OverviewCannabinoids are organic chemical compounds found not just in the oft recognized plant Cannabis sativa, but also in the human neural networks.
This particular property makes them lucrative for pain management.Request Brochure – https://www.transparencymarketresearch.com/sample/sample.php?flag=B_id=78851Besides their recreational usage, cannabinoids find widespread use in the healthcare industry.
Accordingly, few conditions they are used for are chronic pain of any origin, side effects such as vomiting and nausea associated with chemotherapy, anorexia, weight loss, IBS, spasticity, epilepsy, and a variety of psychiatric conditions.
This is helping the global cannabinoid drug market record sturdy growth over the assessment period of TMR’s upcoming report – 2020 to 2030.Global Cannabinoid Drugs Market: Competitive LandscapeThe number of players in the cannabinoid drug market is few, making the market scenario concentrated.
Some of the prominent names in this market are:GW Pharmaceuticals Abbott Laboratories, Valeant Pharmaceuticals International, Indevus Pharmaceuticals, Request COVID Analysis on Cannabinoid Drugs Market – https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19_id=78851Global Cannabinoid Drugs Market: Key Trends and DriversA large number of people across the world are suffering from chronic conditions.
Psychotherapy is demanding cannabinoid intervention on an increased scale given the benefits it has for patients with hyperactive disorders.
With a multi-disciplinary approach, Fact.MR elaborates an extensive analysis of the historical, current and future outlook of the global cannabinoid therapy market as well as the factors responsible for such a growth.
Our highly dedicated professionals have inputted critical and accurate insights associated with every industry, and region by doing thorough primary and secondary research.We leverage space-age industrial and digitalization tools to provide avant-garde actionable insights to our clients regarding the cannabinoid therapy market.
For enhancing readers’ experience, the report starts with a basic overview about the cannabinoid therapy market and its classification.Competitive Assessment The cannabinoid therapy market report includes global as well as emerging players:Zynerba PharmaceuticalsCannabics Pharmaceuticals Inc.GW Pharmaceuticals PLCEnectaAlpha-CATTeewinot Life SciencesTilrayGD PharmaCyrelian Pty Ltd.Cape Bouvard Technologies Pty LtdMedReleaf AustraliaAusCann Group Holdings Pty LtdThe insights for each vendor consists of:Company profileSWOT analysisMain market informationMarket shareRevenue, pricing and gross marginRequest Sample Report - https://www.factmr.com/connectus/sample?flag=S_id=2833 Regional Analysis Important regions covered in the cannabinoid therapy market report include:North AmericaLatin AmericaEuropeJapanThe cannabinoid therapy market report also provides data regarding the key countries in the defined regions.Segmentation AnalysisBy Product:OilsCapsulesIsolatesE-liquidsTopicalsOthersBy end use:HospitalsCancer CentersMilitary Healthcare SettingsRehabilitation CentersOthersWhat insights does the cannabinoid therapy market report provide to the readers?Cannabinoid therapy market fragmentation on the basis of product type, end use, and region.Comprehensive assessment of upstream starting materials, downstream demand, and present market landscape.Collaborations, R projects, acquisitions, and product launches of each cannabinoid therapy market player.Various regulations imposed by the governments on the consumption of cannabinoid therapy market in detail.Impact of modern technologies, such as big data & analytics, artificial intelligence, and social media platforms on the global cannabinoid therapy market.Questionnaire answered in the cannabinoid therapy market report include:What is the present and future outlook of the global cannabinoid therapy market on the basis of region?What are the challenges and opportunities for the cannabinoid therapy market?Why the consumption of cannabinoid therapy market highest in region?In which year segment is expected to overtake segment?Request TOC of this Report - https://www.factmr.com/connectus/sample?flag=T_id=2833And many more …
Global Cannabinoid-based Antitumor Drug Market Growing Demand and Growth Opportunity 2027The report is a comprehensive analysis of the Cannabinoid-based Antitumor Drug market and covers facts and growth drivers for the market profile.
Manufacturing technologies and applications that form a part of this Cannabinoid-based Antitumor Drug market success are also included in the report.
Based on such information, the market has been segmented into various categories and portrays the maximum market share for the forecast period.
The study is a result of various analysis techniques used to derive the relevant information.
These analysis techniques include SWOT methodologies and Porter’s Five Force Model.Further, the report has an acute focus on global players, products with the highest demand, and the various product categories, which are causative of the Cannabinoid-based Antitumor Drug market growth.
The study of the market has been taken place during 2019, the base year and the forecast period stretches till 2027.Top Key Players Profiled in this report: Cannabics Inc., Tikun Olam, Jay Pharma, GW Pharmaceuticals, Medicanja Ltd, and Valeant PharmaceuticalsClick Here To Access The Sample Cannabinoid-based Antitumor Drug Market ReportSegmental AnalysisThe market study contains the division of the overall market into different regional segments according to the key geographic regions.
Vaporizers are made for those looking for an easy-to-use smoking options while remaining discreet on-the-go.
Our cannabis vaporizers offer the highest quality oil, extracted from premium Canadian cannabis.
Vaporizing draws the whole flavor and aroma from your favourite strain, while eliminating the health ricks associated with smoking flower directly.
Haute Health is the best vape shop online in Canada and we guarantee we will become your go to online vape shop.Vaping has become a healthier alternative to smoking flower due to the fact that vapor doesn’t release the tar and carcinogens created during combustion, instead vaporizers create a phase where the cannabis smoke is converted from liquid to vapor.
Most vaporization devices are created to heat cannabis and oil just below the point of combustion (180-190 degrees Celsius), compared to smoking cannabis with a lighter which goes over the point of combustion potentially releasing harmful toxins into your lungs.
Vaping typically produces more dominant flavor than smoking flower.